| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $376.1M | +91.3% |
| Cost of Revenue | $36.7M | +91.8% |
| R&D Expense | $77.1M | +0.8% |
| SG&A Expense | $274.6M | +19.7% |
| Operating Income | -$12.2M | +90.5% |
| Income Tax | $1.2M | +81.0% |
| Net Income | -$16.1M | +88.5% |
| EPS (Basic) | -$0.13 | +88.8% |
| EPS (Diluted) | -$0.13 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.9M | -39.9% |
| Accounts Receivable | $146.2M | +100.1% |
| Inventory | $22.6M | +55.8% |
| Current Assets | $411.2M | +22.5% |
| Total Assets | $433.0M | +24.1% |
| Current Liabilities | $129.8M | +60.3% |
| Long-term Debt | $109.0M | +1.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | +95.0% |
| Capital Expenditures | $686K | +379.7% |
| Investing Cash Flow | -$30.3M | -205.0% |
| Financing Cash Flow | $7.0M | -89.5% |
| Free Cash Flow | -$6.3M | +94.4% |
| +88.8% |
| Total Liabilities |
| $243.5M |
| +27.3% |
| Stockholders' Equity | $189.5M | +20.3% |